IXC 0.00% 6.6¢ invex therapeutics ltd

Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-127

  1. 6,147 Posts.
    lightbulb Created with Sketch. 1652
    Because they have lost credibility judging from the comments on this forum.

    22.6m cash on 75m SOI = 30c cash per share selling at 20c. Mainly tax lose selling now, as its pretty irrational.


 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.